Local Hydrogel Release of Recombinant TIMP-3 Attenuates Adverse Left Ventricular Remodeling After Experimental Myocardial Infarction
Authors:
- 12 February 2014
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 6 (223) , 223ra21
Abstract
Delivery of a hydrogel providing sustained release of recombinant TIMP-3 attenuated adverse ventricular remodeling after myocardial infarction in pigs.Keywords
This publication has 23 references indexed in Scilit:
- Polymer-Based Restoration of Left Ventricular MechanicsCell Transplantation, 2013
- Regulation of the Inflammatory Response in Cardiac RepairCirculation Research, 2012
- Fibroblasts and Myofibroblasts: What Are We Talking About?Journal of Cardiovascular Pharmacology, 2011
- Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine modelProceedings of the National Academy of Sciences, 2010
- Matrix Metalloproteinase InhibitorsDrugs, 2010
- Simultaneous Transforming Growth Factor β-Tumor Necrosis Factor Activation and Cross-talk Cause Aberrant Remodeling Response and Myocardial Fibrosis in Timp3-deficient HeartJournal of Biological Chemistry, 2009
- Large Animal Models of Heart FailureCirculation: Heart Failure, 2009
- Targeted Myocardial Microinjections of a Biocomposite Material Reduces Infarct Expansion in PigsThe Annals of Thoracic Surgery, 2008
- Dynamic Changes in Matrix Metalloprotienase Activity Within the Human Myocardial Interstitium During Myocardial Arrest and ReperfusionCirculation, 2008
- Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblastsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005